Comment on “Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis”
Saved in:
| Main Authors: | Gilles Nevez, Claire Hoffmann, Solène Le Gal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2023/9793264 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.
by: Cecilia T Costiniuk, et al.
Published: (2011-01-01) -
Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
by: James D Heffelfinger, et al.
Published: (2009-01-01) -
Neumonía por Pneumocystis Jirovecii
by: Residencia de Clínica Médica Hospital Italiano de Buenos Aires
Published: (2025-03-01) -
Clinical characteristics of Pneumocystis jirovecii pneumonia in hemodialysis patients
by: Na Young Kim, et al.
Published: (2025-04-01) -
Low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis jirovecii pneumonia in HIV-uninfected patients: a systematic review and meta-analysis
by: Hui-Bin Huang, et al.
Published: (2025-07-01)